Ginkgo Bioworks Hldgs Inc (DNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 55,430 | 80,568 | 80,702 | 98,285 | 66,398 |
| Cost of Goods | 6,923 | 18,096 | 22,375 | 30,218 | 24,655 |
| Gross Profit | 48,507 | 62,472 | 58,327 | 68,067 | 41,743 |
| Operating Expenses | 335,823 | 246,719 | 274,447 | 299,149 | 697,336 |
| Operating Income | -286,393 | -184,151 | -215,745 | -230,864 | -654,938 |
| Other Income | -16,520 | 10,903 | 10,858 | 43,016 | -15,221 |
| Pre-tax Income | -302,913 | -173,248 | -204,887 | -187,848 | -670,159 |
| Income Tax | -22 | 67 | 82 | -14,770 | -28 |
| Net Income Continuous | -302,891 | -173,315 | -204,969 | -173,078 | -670,131 |
| Minority Interests | N/A | N/A | N/A | 2,390 | N/A |
| Net Income | $-302,891 | $-173,315 | $-204,969 | $-175,468 | $-670,131 |
| EPS Basic Total Ops | -6.21 | -3.60 | -4.40 | -2.55 | -16.40 |
| EPS Basic Continuous Ops | -6.21 | -3.59 | -4.28 | -2.45 | -16.44 |
| EPS Diluted Total Ops | -6.21 | -3.60 | -4.40 | -2.60 | -16.40 |
| EPS Diluted Continuous Ops | -6.21 | -3.59 | -4.28 | -2.42 | -16.44 |
| EBITDA(a) | $-265,333 | $-166,499 | $-196,787 | $-215,197 | $-647,025 |